- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Top Growth Stocks
Hong Kong Pharmaceuticals & Biotech Top Growth Stocks
Results
8
8 companies
Cutia Therapeutics
Market Cap: HK$1.5b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$4.16
7D
-5.0%
1Y
-51.9%
Ascentage Pharma Group International
Market Cap: HK$15.3b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$41.64
7D
6.0%
1Y
-17.6%
Ocumension Therapeutics
Market Cap: HK$5.1b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$6.24
7D
-4.7%
1Y
-13.5%
Everest Medicines
Market Cap: HK$11.2b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$31.80
7D
-0.7%
1Y
-25.5%
GenFleet Therapeutics (Shanghai)
Market Cap: HK$12.4b
A biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States.
2595
HK$33.50
7D
-6.2%
1Y
n/a
InSilico Medicine Cayman TopCo
Market Cap: HK$28.8b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$50.40
7D
-4.8%
1Y
n/a
CanSino Biologics
Market Cap: HK$12.0b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$28.06
7D
-0.6%
1Y
-15.6%
WuXi XDC Cayman
Market Cap: HK$72.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.30
7D
4.6%
1Y
55.3%